We are pleased to announced that Star has established a Healthcare and Life Sciences Advisory Board, bringing together experts from across the US healthcare ecosystem to help organizations navigate regulatory change, modernize their data foundations and apply AI responsibly.
The board will give our clients access to more practical expertise spanning connected medical devices, applied AI and innovation, clinical workflows and organizational transformation. Members will apply this experience to client conversations, industry initiatives and thought leadership focused on solving complex healthcare challenges and building more connected, trusted and effective solutions.
Meet our Healthcare and Life Sciences Advisory Board
Our advisory board brings together leaders with complementary expertise across healthcare technology, clinical practice, pharma, MedTech, payer and pharmacy operations and innovation commercialization.
- Dr. Jennifer Bepple is a physician, clinical informaticist and digital health leader focused on improving patient care through clinical innovation, responsible AI and patient-centered technology.
- Rajeev Nair is a pharmaceutical technology executive with extensive experience leading enterprise transformation, data, analytics and AI initiatives across regulated life sciences environments.
- Nias Puthenveettil is a healthcare technology executive, entrepreneur and advisor with more than 25 years of experience in enterprise transformation, scalable AI platforms and connected healthcare solutions.
- Arleisha Strauder, PharmD is a licensed pharmacist with expertise in managed care, pharmacy benefit management, Medicare Part D, prior authorization and utilization management.
- Dr. Jaap Schut is an innovation strategist, materials scientist and entrepreneur with more than two decades of experience in product development, commercialization and healthcare innovation.
Together, they bring perspectives spanning clinical needs, regulatory requirements, technology implementation and commercial priorities.
Why are we established an advisory board
Healthcare and life sciences organizations are navigating significant change. Regulatory requirements continue to evolve, fragmented systems limit the effective use of data and organizations face growing pressure to translate AI investment into practical and measurable value.
Addressing these challenges requires more than technology. It demands a detailed understanding of the clinical, operational, regulatory and commercial environments in which healthcare products and platforms must operate.
The advisory board will complement our existing industry expertise, helping us identify emerging industry needs, deepen our understanding of client challenges and strengthen the practical relevance of the solutions we build.
Our objective is to help pharma, MedTech and payer organizations modernize regulated products and platforms, connect fragmented systems and data through interoperability, comply with regulatory mandates and apply AI responsibly.
“Across pharma, medical device manufacturers and payers, organizations throughout the US healthcare ecosystem must respond to regulatory change, modernize complex data environments and adopt AI responsibly, all while improving care quality and interoperability across systems. By bringing together experts with complementary experience from across the industry, we can add valuable perspectives to Star’s strategy, design and engineering capabilities. Their insights will help us build more relevant solutions with our clients and contribute to a more connected and effective healthcare ecosystem.”
Mahesh Naphade
Global Head of Healthcare and Life Sciences at Star
Members of the advisory board will work with Star through client discussions, articles, interviews and industry events exploring the regulatory, data and AI transformation shaping healthcare and life sciences.
